|
|
|
|
| LEADER |
00962cas a2200289 4500 |
| 001 |
PPN036747025 |
| 005 |
20141016084900.0 |
| 011 |
|
|
|a 1359-5245
|
| 035 |
|
|
|a ccn1359-5245
|
| 100 |
|
|
|a 19950612a198 9999||||0frey0103 ba
|
| 101 |
0 |
|
|a eng
|
| 102 |
|
|
|a GB
|
| 110 |
|
|
|a by|||||||||
|
| 200 |
1 |
|
|a International clinical psychopharmacology. Supplement
|
| 210 |
|
|
|a Oxford
|c Clinical Neuroscience Publications
|
| 422 |
|
| |
|0 039323196
|t International clinical psychopharmacology
|x 0268-1315
|
| 530 |
0 |
|
|a International clinical psychopharmacology. Supplement
|
| 531 |
|
|
|a Int. clin. psychopharmacol., Suppl.
|
| 675 |
|
|
|a 616.89
|
| 801 |
|
3 |
|a FR
|b Abes
|c 20040912
|g AFNOR
|
| 801 |
|
3 |
|a FR
|b Abes
|c 20040912
|g AFNOR
|
| 802 |
|
|
|a 02
|
| 930 |
|
|
|5 441092101:26508900X
|b 441092101
|a P1658 Bis
|j f
|
| 937 |
|
|
|a BU Santé
|c : vol. 8 (1993) - vol. 13 (1998) [lac.]
|f Cote : P1658 Bis
|
| 955 |
4 |
1 |
|5 441092101:26508900X
|a 8
|i 1993
|a 13
|i 1998
|w lac.
|
| 979 |
|
|
|a SAN
|
| 998 |
|
|
|a 459653
|
Nantilus